Direct Allergy

Direct Allergy is a health care startup headquartered in Erie, Pa. The company offers physician support services with customized immunotherapy testing and treatment for allergy sufferers. Founded in 2012, Direct Allergy focuses on providing a more effective and affordable alternative to traditional over-the-counter allergy medications through immunotherapy. This process helps desensitize allergy patients to various allergens, leading to the complete elimination of allergies and enabling individuals to enjoy a higher quality of life without the burden of allergy symptoms. Direct Allergy's services not only benefit allergy sufferers but also provide additional revenue streams for physicians. By offering a broader range of in-house services, physicians can attract more clients and contribute to the overall well-being of their patients. Direct Allergy recently secured a $150.00K Seed Round investment on 11 April 2020, which signifies the interest and potential growth opportunities within the industry. Although the specific investors for this round were not disclosed, this investment will likely fuel the company's expansion and further establish its position within the market. Overall, Direct Allergy presents a promising opportunity for investors seeking to support innovative solutions in the healthcare sector.